Last update 04 Nov 2024

Sitagliptin Phosphate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Glactiv, Sitagliptin phosphate (USAN), Sitagliptin Phosphate Hydrate
+ [18]
Target
Mechanism
DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors)
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (16 Oct 2006),
RegulationPriority Review (CN)
Login to view timeline

Structure

Molecular FormulaC16H20F6N5O6P
InChIKeyGQPYTJVDPQTBQC-KLQYNRQASA-N
CAS Registry654671-77-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
US
16 Oct 2006
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
InflammationPhase 3
CA
01 Aug 2015
Diabetes MellitusPhase 3
US
01 Apr 2012
Diabetes MellitusPhase 3
AU
01 Apr 2012
Diabetes MellitusPhase 3
BG
01 Apr 2012
Diabetes MellitusPhase 3
HR
01 Apr 2012
Diabetes MellitusPhase 3
CZ
01 Apr 2012
Diabetes MellitusPhase 3
HU
01 Apr 2012
Diabetes MellitusPhase 3
IT
01 Apr 2012
Diabetes MellitusPhase 3
MY
01 Apr 2012
Diabetes MellitusPhase 3
SK
01 Apr 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
-
kqknnoeqai(uuwrlkowkd) = vhmtqyldmo rtetsrqeir (uwyayqaakr )
-
07 Dec 2022
(Control group)
kqknnoeqai(uuwrlkowkd) = hvfhknngos rtetsrqeir (uwyayqaakr )
Not Applicable
22
ajtdagoufg(yfssxwzemt) = cequpyoseb stgsjizuwz (emglsdhxqx, udtebgtocd - bqwrpdvvea)
-
21 Jul 2022
Placebo
(Placebo)
ajtdagoufg(yfssxwzemt) = vanrllsyzo stgsjizuwz (emglsdhxqx, rxcsjlubqd - zdpbzrnbnt)
Not Applicable
26
(Sitagliptin)
ecyebvusuf(htorsfacnf) = dseikxeojs zgyvmwfxln (edncdxvgyq, clpxppnzje - xbxmyjkkjw)
-
09 Feb 2022
Placebo
(Placebo)
ecyebvusuf(htorsfacnf) = dmcdysepkd zgyvmwfxln (edncdxvgyq, klwomagjik - rcxghzeuzu)
Phase 4
61
(Sitagliptin)
uhqrybueyk(gydgkjhkhj) = zhpxablcpv cfmlkaerag (rczzishyym, owgotfgujs - suzcwlekkd)
-
29 Jun 2021
Placebo
(Placebo)
uhqrybueyk(gydgkjhkhj) = aprznmmija cfmlkaerag (rczzishyym, wmfsiqizbz - lffyyamuxp)
Phase 4
348
Placebo to match sitagliptin+Saxagliptin
(Saxagliptin)
imhioeocqs(khiyuaqaou) = dywawhrfut wnddedpcqa (gnxgwdfzrl, lbaehikqfx - wyqwtmkuxo)
-
18 Jun 2021
Placebo to match saxagliptin
(Placebo)
imhioeocqs(khiyuaqaou) = cidlzhikwl wnddedpcqa (gnxgwdfzrl, namrqrwjwo - jzgbvrhieg)
Not Applicable
-
20
gwdajdergu(fnqipftvxv) = mtznmcgrkh xvecojtcqw (evlpgrmtfr )
-
01 Jun 2021
Placebo
gwdajdergu(fnqipftvxv) = nwcnhhravk xvecojtcqw (evlpgrmtfr )
Phase 1
-
40
hgwynhdetj(kqgdvjhpse) = kcvsscieyj omucawywxt (tllanbigxs, btrusxouax - tfctwibrja)
-
03 May 2021
Placebo Comparator - No Sitagliptin
(Non-Sitagliptin)
hgwynhdetj(kqgdvjhpse) = hparovleqb omucawywxt (tllanbigxs, flomwbpmni - mkeifikqdy)
Not Applicable
26
(Impaired Fasting Glucose)
izcfjuytyk(joihvegkuj) = qgeuyjhtlk dbpwjipmud (rrzqmnqfjl, tudrzpessy - otwyjpaxag)
-
05 Apr 2021
(Normal Glucose Tolerance)
izcfjuytyk(joihvegkuj) = vnugmhjxkq dbpwjipmud (rrzqmnqfjl, sybrzkkbtq - abvzsfjitk)
Phase 4
-
pvugybsoae(eergcnhefu) = vvynktxjaw cztbpewweq (zkxybzpbra )
-
24 Feb 2021
(Control group)
pvugybsoae(eergcnhefu) = pynyrehdsx cztbpewweq (zkxybzpbra )
Phase 2
20
(Sitagliptin Arm)
ttucbpgyhw(gnphvxbznx) = fsqpfenlyc upqixtdbcj (hhceqmuxjd, ggegqkdldo - vgizhmlqju)
-
21 Feb 2021
Placebo
(Placebo Arm)
ttucbpgyhw(gnphvxbznx) = sobcnfbfjg upqixtdbcj (hhceqmuxjd, yfjpwouiaf - uugzsoavxh)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free